Baicalein antagonizes rotenone-induced apoptosis in dopaminergic SH-SY5Y cells related to Parkinsonism

BackgroundTwo active compounds, baicalein and its glycoside baicalin were found in the dried root of Scutellaria baicalensis Georgi, and reported to be neuroprotective in vitro and in vivo. This study aims to evaluate the protective effects of baicalein on the rotenone-induced apoptosis in dopaminergic SH-SY5Y cells related to parkinsonism.MethodsCell viability and cytotoxicity were determined by MTT assay. The degree of nuclear apoptosis was evaluated with a fluorescent DNA-binding probe Hoechst 33258. The production of reactive oxidative species (ROS) and loss of mitochondrial membrane potential (ΔΨm) were determined by fluorescent staining with DCFH-DA and Rhodanmine 123, respectively. The expression of Bax, Bcl-2, cleaved caspase-3 and phosphorylated ERK1/2 was determined by the Western blots.ResultsBaicalein significantly increased viability and decreased rotenone-induced death of SH-SY5Y cells in a dose-dependent manner. Pre- and subsequent co-treatment with baicalein preserved the cell morphology and attenuated the nuclear apoptotic characteristics triggered by rotenone. Baicalein antagonized rotenone-induced overproduction of ROS, loss of ΔΨm, the increased expression of Bax, cleaved caspase-3 and phosphorylated ERK1/2 and the decreased expression of Bcl-2.ConclusionThe antioxidative effect, mitochondrial protection and modulation of anti-and pro-apoptotic proteins are related to the neuroprotective effects of baicalein against rotenone induced cell death in SH-SY5Y cells.

[1]  J. T. Greenamyre,et al.  Neurotoxic in vivo models of Parkinson's disease recent advances. , 2010, Progress in brain research.

[2]  W. Rostène,et al.  Baicalein protects cortical neurons from beta-amyloid (25-35) induced toxicity. , 2001, Neuroreport.

[3]  Chao Liu,et al.  Neuroprotection by baicalein in ischemic brain injury involves PTEN/AKT pathway , 2010, Journal of neurochemistry.

[4]  Junli Ye,et al.  Neuroprotective Effect of Baicalein on Hydrogen Peroxide-Mediated Oxidative Stress and Mitochondrial Dysfunction in PC12 Cells , 2010, Journal of Molecular Neuroscience.

[5]  Claudia M Testa,et al.  Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures. , 2005, Brain research. Molecular brain research.

[6]  Won Bok Lee,et al.  Baicalein attenuates 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells. , 2005, European journal of cell biology.

[7]  G. Du,et al.  Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro , 2009, Pharmacology Biochemistry and Behavior.

[8]  L. Tremblay,et al.  Experimental Models of Parkinson’s Disease , 2002, Annales pharmaceutiques francaises.

[9]  G. Du,et al.  Neuroprotective effect of baicalein against MPTP neurotoxicity: Behavioral, biochemical and immunohistochemical profile , 2008, Neuroscience Letters.

[10]  Xian-Jun Qu,et al.  Baicalin attenuates focal cerebral ischemic reperfusion injury through inhibition of nuclear factor κB p65 activation. , 2010, Biochemical and biophysical research communications.

[11]  P. Shaw,et al.  Chrysotoxine, a novel bibenzyl compound, inhibits 6-hydroxydopamine induced apoptosis in SH-SY5Y cells via mitochondria protection and NF-κB modulation , 2010, Neurochemistry International.

[12]  N. Zhang,et al.  [Protective effect of baicalin on mouse with Parkinson's disease induced by MPTP]. , 2007, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.

[13]  Ji Hyun Choi,et al.  Baicalein protects HT22 murine hippocampal neuronal cells against endoplasmic reticulum stress-induced apoptosis through inhibition of reactive oxygen species production and CHOP induction , 2010, Experimental & Molecular Medicine.

[14]  P. Wong,et al.  Hydrogen Sulfide Inhibits Rotenone-Induced Apoptosis via Preservation of Mitochondrial Function , 2009, Molecular Pharmacology.

[15]  Khaled Radad,et al.  Rotenone induces cell death in primary dopaminergic culture by increasing ROS production and inhibiting mitochondrial respiration , 2006, Neurochemistry International.

[16]  A. Chinnaiyan,et al.  The CED-3/ICE-like Protease Mch2 Is Activated during Apoptosis and Cleaves the Death Substrate Lamin A* , 1996, The Journal of Biological Chemistry.

[17]  J. Brotchie,et al.  The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future. , 2010, Progress in brain research.

[18]  Wei Du,et al.  Baicalein is neuroprotective in rat MCAO model: Role of 12/15-lipoxygenase, mitogen-activated protein kinase and cytosolic phospholipase A2 , 2010, Pharmacology Biochemistry and Behavior.

[19]  Erwan Bezard,et al.  Novel pharmacological targets for the treatment of Parkinson's disease , 2006, Nature Reviews Drug Discovery.

[20]  Todd B. Sherer,et al.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.

[21]  Heh-In Im,et al.  Baicalein prevents 6-hydroxydopamine-induced dopaminergic dysfunction and lipid peroxidation in mice. , 2005, Journal of pharmacological sciences.

[22]  C. Chi,et al.  Effects of baicalein on -amyloid peptide-(2535)-induced amnesia in mice , 2004 .

[23]  M. Barrachina,et al.  MPP+ increases α-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells , 2002, Brain Research.

[24]  G. Du,et al.  Baicalein protects the brain against neuron impairments induced by MPTP in C57BL/6 mice , 2011, Pharmacology Biochemistry and Behavior.

[25]  C. Chi,et al.  Effects of baicalein on beta-amyloid peptide-(25-35)-induced amnesia in mice. , 2004, European journal of pharmacology.

[26]  B. Manyam,et al.  Traditional and complementary therapies in Parkinson's disease. , 1999, Advances in neurology.

[27]  M. Barrachina,et al.  MPP+ increases alpha-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells. , 2002, Brain research.

[28]  M. Watabe,et al.  Mitochondrial Complex I Inhibitor Rotenone-Elicited Dopamine Redistribution from Vesicles to Cytosol in Human Dopaminergic SH-SY5Y Cells , 2007, Journal of Pharmacology and Experimental Therapeutics.

[29]  D. Zack,et al.  Baicalein reduces E46K α‐synuclein aggregation in vitro and protects cells against E46K α‐synuclein toxicity in cell models of familiar Parkinsonism , 2010, Journal of neurochemistry.

[30]  P. Mastroberardino,et al.  Lessons from the rotenone model of Parkinson's disease. , 2010, Trends in pharmacological sciences.

[31]  C. Borner.  The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. , 2003, Molecular immunology.

[32]  A. Chinnaiyan,et al.  Molecular Ordering of the Cell Death Pathway , 1996, The Journal of Biological Chemistry.

[33]  Qin Li,et al.  Traditional Chinese medicine for Parkinson's disease: a review of Chinese literature , 2006, Behavioural pharmacology.

[34]  Qiang Wu,et al.  Phosphorylated-ERK 1/2 and neuronal degeneration induced by rotenone in the hippocampus neurons. , 2009, Environmental toxicology and pharmacology.

[35]  Simon C Watkins,et al.  Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death. , 2007, The American journal of pathology.

[36]  C. Horbinski,et al.  6-Hydroxydopamine induces mitochondrial ERK activation. , 2007, Free radical biology & medicine.

[37]  W. Rostène,et al.  Baicalein protects cortical neurons from β-amyloid (25-35) induced toxicity , 2001 .

[38]  Zhan-jun Zhang,et al.  Baicalin administration is effective in positive regulation of twenty-four ischemia/reperfusion-related proteins identified by a proteomic study , 2009, Neurochemistry International.